CNR1 and metabolic dysfunction-associated steatotic liver disease: Functional studies also indicated opposing effects of CB1R and CB2R, with CB2R activation consistently showing positive lipid metabolic outcomes, such as preventing obesity, nonalcoholic fatty liver disease, and diabetes [32, 33, 34].